Seattle biotech startup Curi Bio lands $10M to expand its R&D support for drug discovery Seattle biotech startup Curi Bio today announced $10 million in new funding. The company enables the screening of new drugs using 3D tissue models. Read More
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize a platform that… Read More
Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance… Read More
